Literature DB >> 26895892

Predictors for regional lymph node metastasis in T1 rectal cancer: a population-based SEER analysis.

Walter Brunner1, Bernhard Widmann2, Lukas Marti1, Ignazio Tarantino1,3, Bruno M Schmied1, Rene Warschkow1,4.   

Abstract

BACKGROUND: Local resection of early-stage rectal cancer significantly reduces perioperative morbidity compared with radical resection. Identifying patients at risk of regional lymph node metastasis (LNM) is crucial for long-term survival after local resection.
METHODS: Patients after oncological resection of T1 rectal cancer were identified in the Surveillance, Epidemiology, and End Results register 2004-2012. Potential predictors of LNM and its impact on cancer-specific survival were assessed in logistic and Cox regression with and without multivariable adjustment.
RESULTS: In total, 1593 patients with radical resection of T1 rectal cancer and a minimum of 12 retrieved regional lymph nodes were identified. The overall LNM rate was 16.3 % (N = 260). A low risk of LNM was observed for small tumor size (P = 0.002), low tumor grade (P = 0.002) and higher age (P = 0.012) in multivariable analysis. The odds ratio for a tumor size exceeding 1.5 cm was 1.49 [95 % confidence interval (CI) 1.06-2.13], for G2 and G3/G4 carcinomas 1.69 (95 % CI 1.07-2.82) and 2.72 (95 % CI 1.50-5.03), and for 65- to 79-year-old and over 80-year-old patients 0.65 (95 % CI 0.43-0.96) and 0.39 (95 % CI 0.18-0.77), respectively. Five-year cancer-specific survival for patients with LNM was 90.0 % (95 % CI 85.3-95.0 %) and for patients without LNM 97.1 % (95 % CI 95.9-98.2 %, hazard ratio = 3.21, 95 % CI 1.82-5.69, P < 0.001).
CONCLUSIONS: In this population-based analysis, favorable cancer-specific survival rates were observed in nodal-negative and nodal-positive T1 rectal cancer patients after primary radical resection. The predictive value of tumor size, grading and age for LNM should be considered in medical decision making about local resection.

Entities:  

Keywords:  Lymph node metastasis; Rectal cancer; Surveillance, Epidemiology, and End Results (SEER)

Mesh:

Year:  2016        PMID: 26895892     DOI: 10.1007/s00464-016-4759-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  36 in total

1.  Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

Authors:  R C Flanigan; S E Salmon; B A Blumenstein; S I Bearman; V Roy; P C McGrath; J R Caton; N Munshi; E D Crawford
Journal:  N Engl J Med       Date:  2001-12-06       Impact factor: 91.245

Review 2.  Endoscopic mucosal resection of flat and depressed types of early colorectal cancer.

Authors:  S Kudo
Journal:  Endoscopy       Date:  1993-09       Impact factor: 10.093

Review 3.  Quality of life after rectal resection for cancer, with or without permanent colostomy.

Authors:  Jørn Pachler; Peer Wille-Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

4.  Short-term outcomes after laparoscopic-assisted proctectomy for rectal cancer: results from the ACS NSQIP.

Authors:  David Yu Greenblatt; Victoria Rajamanickam; Andrew J Pugely; Charles P Heise; Eugene F Foley; Gregory D Kennedy
Journal:  J Am Coll Surg       Date:  2011-03-16       Impact factor: 6.113

5.  Routine use of transrectal ultrasound in rectal carcinoma: results of a prospective multicenter study.

Authors:  F Marusch; A Koch; U Schmidt; R Zippel; R Kuhn; S Wolff; M Pross; A Wierth; I Gastinger; H Lippert
Journal:  Endoscopy       Date:  2002-05       Impact factor: 10.093

6.  Immediate radical resection after local excision of rectal cancer: an oncologic compromise?

Authors:  Dieter Hahnloser; Bruce G Wolff; David W Larson; Jennifer Ping; Santhat Nivatvongs
Journal:  Dis Colon Rectum       Date:  2005-03       Impact factor: 4.585

7.  Accuracy of high-resolution magnetic resonance imaging in preoperative staging of rectal cancer.

Authors:  Takayuki Akasu; Gen Iinuma; Masashi Takawa; Seiichiro Yamamoto; Yukio Muramatsu; Noriyuki Moriyama
Journal:  Ann Surg Oncol       Date:  2009-07-18       Impact factor: 5.344

8.  Building the infrastructure for nationwide cancer surveillance and control--a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States).

Authors:  Phyllis A Wingo; Patricia M Jamison; Robert A Hiatt; Hannah K Weir; Paul M Gargiullo; Mary Hutton; Nancy C Lee; H Irene Hall
Journal:  Cancer Causes Control       Date:  2003-03       Impact factor: 2.506

9.  Prognostic value of tumor "budding" in patients with colorectal cancer.

Authors:  K Hase; C Shatney; D Johnson; M Trollope; M Vierra
Journal:  Dis Colon Rectum       Date:  1993-07       Impact factor: 4.585

10.  Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients.

Authors:  I Tarantino; R Warschkow; M Worni; K Merati-Kashani; D Köberle; B M Schmied; S A Müller; T Steffen; T Cerny; U Güller
Journal:  Br J Cancer       Date:  2012-06-26       Impact factor: 7.640

View more
  11 in total

1.  The risk-benefit trade-off in local excision of early rectal cancer.

Authors:  Chang Hyun Kim
Journal:  Ann Coloproctol       Date:  2022-04-14

2.  A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes.

Authors:  Tsuyoshi Ozawa; Raju Kandimalla; Feng Gao; Hiroaki Nozawa; Keisuke Hata; Hiroshi Nagata; Satoshi Okada; Daisuke Izumi; Hideo Baba; James Fleshman; Xin Wang; Toshiaki Watanabe; Ajay Goel
Journal:  Gastroenterology       Date:  2017-12-02       Impact factor: 22.682

Review 3.  Management of complex polyps of the colon and rectum.

Authors:  Fernando A Angarita; Adina E Feinberg; Stanley M Feinberg; Robert H Riddell; J Andrea McCart
Journal:  Int J Colorectal Dis       Date:  2017-12-28       Impact factor: 2.571

4.  Association Between Chemotherapy and Survival in T1 Colon Cancer With Lymph Node Metastasis: A Propensity-Score Matched Analysis.

Authors:  Wangxin Yan; Huizhen Zhou; Si Shi; Jixu Lin; Qiangkang Lin
Journal:  Front Oncol       Date:  2021-07-30       Impact factor: 6.244

5.  Clinicopathological features of small T1 colorectal cancers.

Authors:  Yuki Takashina; Shin-Ei Kudo; Katsuro Ichimasa; Yuta Kouyama; Kenichi Mochizuki; Yoshika Akimoto; Yasuharu Maeda; Yuichi Mori; Masashi Misawa; Noriyuki Ogata; Toyoki Kudo; Tomokazu Hisayuki; Takemasa Hayashi; Kunihiko Wakamura; Naruhiko Sawada; Toshiyuki Baba; Fumio Ishida; Kazunori Yokoyama; Mitsuru Daita; Tetsuo Nemoto; Hideyuki Miyachi
Journal:  World J Clin Cases       Date:  2021-11-26       Impact factor: 1.337

6.  Histological grades of rectal cancer: whole-volume histogram analysis of apparent diffusion coefficient based on reduced field-of-view diffusion-weighted imaging.

Authors:  Yang Peng; Hao Tang; Xiaoyan Meng; Yaqi Shen; Daoyu Hu; Ihab Kamel; Zhen Li
Journal:  Quant Imaging Med Surg       Date:  2020-01

7.  Population-based analysis on predictors for lymph node metastasis in T1 colon cancer.

Authors:  Xin Xu; Chihao Zhang; Xiaochun Ni; Jugang Wu; Chunpeng Pan; Shoulian Wang; Jiwei Yu
Journal:  Surg Endosc       Date:  2019-10-16       Impact factor: 4.584

8.  Long-term oncological outcomes of local excision versus radical resection for early colorectal cancer in young patients without preoperative chemoradiotherapy: a population-based propensity matching study.

Authors:  Bin Cao; Li Min; Shengtao Zhu; Haiyun Shi; Shutian Zhang
Journal:  Cancer Med       Date:  2018-05-03       Impact factor: 4.452

9.  Recursive Partitioning Analysis for Local Control Achieved With Stereotactic Body Radiation Therapy for the Liver, Spine, or Lymph Nodes.

Authors:  Roman O Kowalchuk; Michael R Waters; Sunil W Dutta; Marie L Mack; K Martin Richardson; Kelly Spencer; Kara D Romano; James M Larner; Jason P Sheehan; C Ronald Kersh
Journal:  Adv Radiat Oncol       Date:  2020-11-10

10.  Preoperative Predictors of Lymph Node Metastasis in Colon Cancer.

Authors:  Yansong Xu; Yi Chen; Chenyan Long; Huage Zhong; Fangfang Liang; Ling-Xu Huang; Chuanyi Wei; Shaolong Lu; Weizhong Tang
Journal:  Front Oncol       Date:  2021-05-31       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.